Key research:
– Infectious diseases (correlated to the area of interest: Disease Drug Efficacy)
– Pharmacogenetics and Taxonomy of Human Diseases (correlated to the area of interests: Patient, Diseases, Knowledge)
– Stem Cells for Drug Development and Toxicity Screening (correlated to the area of interests: tools)
Who can apply:
– large biopharmaceutical companies that are members of EFPIA,
– and a variety of other partners, such as:
– small- and medium-sized enterprises,
– patients’ organisations,
– universities and other research organisations,
– hospitals,
– regulatory agencies,
– any other industrial partners.
The IMI financial contribution:
– For research and technological development activities, up to 75% of the eligible costs and
– For other activities (including management and training activities) up to 100%
Budget: maximum EUR 143 300 000.
Submissions deadline: 19 March 2013 – 13:00:00 hours Brussels time (CET)
More information: http://www.imi.europa.eu/sites/default/files/uploads/documents/8th_Call/IMI_8thCallText_FINAL.pdf
További információ: Dr. Pörzse Gábor
igazgató
Semmelweis Pályázati és
Innovációs Központ Kft.
1094 Budapest, Ferenc tér 15.
Tel.: 459-1500/53820
Fax: 459-1589
E-mail: innov@palyazat-sote.hu
Web: www.palyazat-sote.hu
